Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor modulates brain sphingomyelin metabolism.

E Latorre1, M D Aragonés, I Fernández

  • 1Departamento De Bioquimica y Biología Molecular I. Facultad de Químicas, Universidad Complutense de Madrid, Spain.

European Journal of Biochemistry
|May 21, 1999
PubMed
Summary

Platelet-activating factor (PAF) regulates brain ceramide levels by accelerating the sphingomyelin (SM) cycle. PAF prevents SMase-induced changes in SM and ceramide, suggesting a role in sphingolipid metabolism.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between antibiotic use and pathologic response to neoadjuvant chemotherapy in breast cancer: a multicentre retrospective cohort study.

Breast (Edinburgh, Scotland)·2026
Same author

Catalyst-free insertion of carbon monoxide into terminal Mg-C(sp<sup>3</sup>) bonds.

Chemical communications (Cambridge, England)·2026
Same author

Ongoing multiparameter unrest at the Montagne Pelée volcano on Martinique from 2019 to 2024.

Scientific reports·2025
Same author

A Pilot Randomized Control Trial to Assess the Adjunctive Effect of Diet on Response to Advanced Therapies in Patients With Ulcerative Colitis.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

Exploring the broad-spectrum activity of carbohydrate-based Iberin analogues: From anticancer effect to antioxidant properties.

European journal of medicinal chemistry·2025
Same author

Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain.

BMC geriatrics·2024

Area of Science:

  • Neuroscience
  • Biochemistry
  • Cell Biology

Background:

  • Sphingolipids, including sphingomyelin (SM) and ceramide, play crucial roles in cellular signaling and function within the brain.
  • Platelet-activating factor (PAF) is a potent lipid mediator involved in various physiological and pathological processes.

Purpose of the Study:

  • To investigate the modulatory action of platelet-activating factor (PAF) on sphingolipid metabolism in cerebral cortical slices.
  • To elucidate the mechanisms by which PAF influences sphingomyelin and ceramide levels.

Main Methods:

  • Incubation of rat cerebral cortical slices with PAF and/or SMase.
  • Treatment with PAF receptor antagonist (WEB 2086), ceramidase inhibitor (OE), and glucosylceramide synthase inhibitor (PDMP).
  • Analysis of sphingomyelin and ceramide levels using radiolabeled precursors ([14C]serine, [14C]arachidonate, phosphatidyl [N-methyl-3H]choline).

Related Experiment Videos

Main Results:

  • PAF treatment partially prevented SMase-induced reciprocal alterations in SM and ceramide levels in a dose-dependent manner.
  • The effect of PAF was receptor-mediated, as indicated by blockade with WEB 2086.
  • PAF did not affect basal lipid levels but modulated SMase-evoked changes, suggesting an acceleration of the SM cycle.

Conclusions:

  • PAF regulates cellular ceramide levels in the brain by accelerating the sphingomyelin cycle.
  • The findings suggest a novel role for PAF in modulating sphingolipid turnover in the central nervous system.